Forwardly, Inc. Provides Shareholder Update
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 10 2025
0mins
Source: Newsfilter
SEC Filing Update: Forwardly, Inc. has withdrawn its S-1 filing due to SEC objections and will instead file under the 1940 Act, with hopes of returning to the 1934 Act later in 2025.
Partnership Developments: Forwardly's partner, Ligand Innovation Global, is nearing FDA approval for a portable ventilator in Nigeria and Ghana, potentially leading to significant orders, although the situation remains speculative.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
